Leading

quant Healthcare Fund

Benchmark Index
  • S&P BSE Healthcare TRI
Plans
  • Regular
  • Direct
Riskometer
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them

Fund Details(quant Healthcare Fund)

Investment Objective The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
Category of Scheme Thematic
Type of Scheme An open ended equity scheme investing in healthcare sector
Inception Date 17-Jul-23
Lock in Period Nil
Minimum Application Amount For new investor, INR 5000/- and any amount thereafter For existing investors, INR 1000/- and any amount thereafter For Systematic Investment Plan (SIP), the minimum amount is INR 1000/- and in multiples of INR 1/- thereafter.
Benchmark Index S&P BSE Healthcare TRI
Load Structure Entry Load - Nil
Exit Load -15 Days / 1% Effective From August 11,2023
Asset Allocation Pattern
Under normal circumstances, the asset allocation pattern will be as follows Indicative allocations (% of total assets) Risk Profile
Instrument Minimum Maximum High/Medium/Low
Equity and Equity related instruments in Healthcare space 80 100 Very High
Equity and equity related instruments other than Healthcare space 0 20 Very High
Foreign securities including ADRs / GDRs / Foreign equity and debt securities and Overseas ETFs 0 20 Very High Debt & Money Market instrument 0 20 Very High
Debt & Money Market instruments* 0 20 Low to Medium
Units issued by REITs & InvITs 0 5 Very High

The Scheme does not intend to invest in securities with Structured Obligations or Credit Enhancements. The Scheme does not intend to invest in debt instruments with special features in line with SEBI Circular no. SEBI/HO/IMD/DF4/CIR/P/2021/032 dated March 10,2021


* In line with SEBI Circular dated November 29, 2022, the scheme shall not invest more than:

a. 10% of its NAV in debt and money market securities rated AAA;


b. 8% of its NAV in debt and money market securities rated AA;


c. 6% of its NAV in debt and money market securities rated A and below: issued by a single issuer.

The above investment limits may be extended by up to 2% of the NAV of the scheme with prior approval of the Board of Trustees and Board of Directors of the AMC, subject to compliance with the overall 12% limit specified in clause 1 of Seventh Schedule of SEBI MFRegulation.

The investment pattern stated above is indicative and may be changed due to market conditions. The proportion of the scheme invested in each type of security will vary in accordance with microeconomic & macroeconomic conditions, interest rates, and other relevant considerations. These instances may be beyond the control of the fund manager & the AMC and hence may require such deviations. Such changes in the investment pattern will be transitionary in nature and will be undertaken as defensive considerations only in accordance with SEBI circular dated March 04, 2021. Defensive considerations may be determined by the fund manager and in case of deviations on account of exogenous factors, the fund manager will endeavor to rebalance the Scheme within 30 calendar days from the date of such deviation. The intention being at all times to seek to protect the interests of the Unit holders. The risks associated with each investment are an important factor as well. The net assets of this scheme shall predominantly be invested as per the investment pattern stated above.

Fund Manager Mr. Sandeep Tandon, Mr. Ankit Pande, Mr. Sanjeev Sharma, Mr. Vasav Sahgal
Plans Available Regular Plan and Direct Plan.
(The Regular and Direct plan will have a common portfolio)
Options Available 1. Growth Option and 2. IDCW The IDCW option has the following facilities: (i) IDCW Reinvestment Facility. (ii) IDCW Pay-out Facility. Default Investment option is Growth Option. For the IDCW option, the default facility will be IDCW Reinvestment.
Applicable NAV The NAV applicable for purchase or redemption or switching of Units based on the time of the Business Day on which the application is time stamped
Risk Factors For detailed scheme/securities related risk factors, please refer to the Scheme Information Document
Investment Strategy The scheme seeks to achieve its investment objective by investing at least 80% of its net assets in equity /equity related instruments of companies in the Healthcare Sector. The Fund Manager will follow the AMFI sector classification for deciding the investment universe for the scheme. The scheme may also invest some portion of the investible funds in equity / equity related instruments of other companies. The Scheme may also invest some portion of the investible funds in debt and money market instruments. The stocks under the scheme will be selected after rigorous fundamental research which includes parameters like management competitiveness, business competitiveness, corporate governance, growth prospects, past track record etc.
Additionally, the portfolio will be constructed on the basis of various broad factors such as prevailing market conditions, domestic and global economic scenarios, business and consumer sentiment, risk indicators, and a host of proprietary indicators (corporate, geopolitical, sociocultural, economic, regulatory etc.) forming part of our Predictive Analytics suite. Coupled with our signature VLRT Framework, as our established risk mitigation tool, the data will be translated to put forth different scenarios that will highlight relevant stocks for portfolio construction.
To achieve the investment objective, the scheme will invest in equity and equity linked instruments which invests into companies that are part of healthcare theme across market capitalization viz. Large cap, mid cap and small cap companies as defined under SEBI circular no. SEBI/HO/IM/DF3/CIR/P/2017/114 dated October 6, 2017 and SEBI circular no. SEBI/HO/IMD/DF3/CIR/P/2020/172 dated September 11, 2020 as may be amended by SEBI from time to time.
The fund manager may, from time to time, review and modify the Scheme’s investment strategy if such changes are considered to be in the best interests of the unitholders and if market conditions warrant it. No assurance can be given that the fund manager will be able to identify or execute such strategies. The Scheme may also invest a part of its corpus in overseas markets in unlisted securities, Global Depository Receipts (GDRs), ADRs, overseas equity, bonds and mutual funds and such other instruments as may be allowed under the Regulations from time to time.
Statutory Details: Sponsor: quant Capital Finance & Investments Private Limited
Investment Manager:quant Money Managers Limited. CIN: U74899MH1995PLC324387
For Further Details :- https://quantmutual.com/downloads/factsheet
"*Mutual Fund investments are subject to market risks, read all scheme related documents carefully."
Copyright © 2018 All rights reserved quant Money Managers Limited
Designed and Developed by CMOTS Infotech ( ISO 9001:2015 certified )
Mutual fund investments are subject to market risks, read all scheme related documents carefully